Status:
COMPLETED
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)
Lead Sponsor:
University of Cincinnati
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcoholism
Alcohol Abuse
Eligibility:
All Genders
21-65 years
Phase:
PHASE2
Brief Summary
This study is being done to determine if citalopram is safe and effective in the treatment of alcohol dependence. A second purpose is to evaluate whether alcohol dependent individuals who differ in a ...
Detailed Description
Relapse to alcoholism remains a vexing clinical and national health problem. Efforts to match alcohol dependent patients to specific treatments based on their clinical characteristics have produced mi...
Eligibility Criteria
Inclusion
- Outpatients with a diagnosis of DSM-IV alcohol dependence
- Not morbidly obese or underweight
- Express desire to quit or cut down on drinking for duration of trial
Exclusion
- Clinically significant laboratory evidence of diseases
- Have active psychological disorders other than alcoholism
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00249405
Start Date
February 1 2005
End Date
October 1 2010
Last Update
November 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cincinnati
Cincinnati, Ohio, United States, 45237